| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| WST has a current Overall Rating of C (Neutral). | 7 |
$25 |
| 27-Nov-2009 | Validea |
N/A
| Validea Guru Analysis Report for WST. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. | 0 |
$18 |
| 26-Nov-2009 | New Constructs, LLC |
N/A
| WST: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 26-Nov-2009 | Pechala's Reports | Lubomir Pechala | WEST PHARMACEUTICAL SERVICES INC (WST=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 24-Nov-2009 | Standard & Poor's Factual Report |
N/A
| West Pharmaceutical Services | 8 |
$35 |
| 24-Nov-2009 | Jefferson Research |
N/A
| Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of WEST PHARMACEUTICAL SVSC INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 |
$20 |
| 24-Nov-2009 | Zacks Investment Research Inc. |
N/A
| WEST PHARM SVC (WST) Zacks Company Snapshot | 1 |
$10 |
| 23-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Rubber, Plastic & Glass Intelligence Monitor: overall outlook VERY STRONG - 15 new Leaders; 2 new Laggards. | 32 |
$20 |
| 23-Nov-2009 | Reuters Investment Profile |
N/A
| West Pharmaceutical Services Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Chemicals, Coatings & Plastics Industry Market Research and Competitive Analysis 2010 | 561 |
$299 |
1.48% Nasdaq 
Research Reports
